Opens in a new tab

At-Home Blood Tests for Healthy People: What a New Study Found

Table of Content

At-home blood test kit on a kitchen table with a sample tube and a tablet showing a results chart

⚕️ This article is for informational purposes only and does not replace medical advice. Always consult your doctor to interpret your results.

On November 17, 2026, the journal BMJ Open published a study that looked closely at the health tests sold online to people who feel perfectly well: blood, urine, stool and saliva tests, scans and physical exams. Its conclusion is blunt. Many of these checkups promise more than they can deliver, and most say little or nothing about their downsides.

The study covers the United Kingdom, but the question matters just as much in the United States, where an at-home blood test or a lab panel can be ordered online in a few clicks and searches for "at home blood test" have climbed sharply over the past year. Here is what the researchers found, how it applies to US screening advice, and how to tell a useful test from an unnecessary one.

What the BMJ Open study looked at

Researchers at the University of St Andrews in Scotland identified 50 vendors (companies, clinics and individual practitioners, including the biggest names in the sector) that market screening tests to people without symptoms. They compared what was on sale with the recommendations of the NHS, the UK's public health service, and recorded the claims made on each website. A group of members of the public was also asked why people buy these tests.

The market is growing fast: according to the study, it is expected to double from $1.6 billion in 2023 to $3.2 billion in 2029. Prices ranged from under £7 for a home urine test to £14,000 for a clinic "Platinum" assessment.

Tests sold outside the guidelines

A large share of the tests were offered to people the NHS does not recommend testing:

Test offeredWho vendors offered it toNumber of vendors (out of 50)
Lipid panel (cholesterol) and HbA1cHealthy adults under 4045
FSH hormone testAll women over 4531
qFIT stool test for hidden bloodAdults under 5028
MammogramAverage-risk women under 50 without symptoms12

Some of these age limits are specific to the UK. In the United States, the US Preventive Services Task Force (USPSTF) recommends a mammogram every two years from age 40 and colorectal cancer screening from age 45, and the American Heart Association advises a cholesterol test for adults from age 19. The point of the study is not the exact cut-off, but that tests were sold to everyone, regardless of age, risk or national advice. The FSH test is a good example: this hormone swings widely from month to month during perimenopause, so a single result says little, and UK guidance does not use it to diagnose menopause after 45.

Big promises, few warnings

The claims were overwhelmingly upbeat: better knowledge of your health (48 vendors), earlier diagnosis and better outcomes (36), reassurance (25), and even living longer (16 vendors), a promise the authors say no evidence supports. By contrast, about 70% of vendors did not explain the limitations or possible harms of testing. Only 15 mentioned any downside at all: false positives or overdiagnosis (9), false negatives (8) and inaccuracy (9).

The people interviewed valued easy access and hoped the results would help their conversations with their doctors. Above all, they said they needed help understanding their results, help that several clinics offered only for an extra fee. The authors note that UK family doctors already spend time following up results they never ordered, and they call for regulatory gaps on health claims to be closed urgently.

Why testing healthy people is not harmless

A screening test is only worthwhile when it is offered to the right people at the right time, and when an abnormal result leads to care that actually improves health. In a person without symptoms and at low risk, most diseases are rare, so a good share of "abnormal" results are false positives that bring anxiety, more tests and sometimes invasive procedures. A normal result, on the other hand, can falsely reassure someone and delay a visit when symptoms appear.

The more markers you measure, the more likely one of them will land outside the range by chance. Lab reference ranges usually cover 95% of healthy people, which means roughly one healthy person in twenty will have an "out-of-range" result for each marker tested.

What this means in the United States

In most states you can order many lab tests yourself, and the FDA lists home-use tests it has cleared or approved. The FDA reminds consumers that home test results are best interpreted together with a medical history, a physical exam and other testing, and that they should not replace regular visits to a doctor. Researchers have also pointed out that direct-to-consumer lab tests often escape part of the oversight that applies to tests ordered through a clinician.

Evidence-based preventive care is often already covered by insurance, including the Medicare Annual Wellness Visit for people 65 and older, and guideline-based screenings such as mammography and colorectal cancer screening.

Which tests can monitor or screen for this?

Rather than a 100-marker checkup, a few targeted tests have proven value when they are done at the right time:

  • A lipid panel (total, LDL and HDL cholesterol, triglycerides) to estimate heart risk.
  • Fasting glucose or HbA1c, which the USPSTF recommends for adults 35 to 70 who have overweight or obesity.
  • A stool test or colonoscopy for colorectal cancer screening from 45; a positive FIT test needs a follow-up colonoscopy.
  • A comprehensive blood panel ordered for a clear reason (fatigue, monitoring a medicine, a chronic condition) rather than "just to see".

For FSH, talk with your doctor first: after 45, menopause is mainly diagnosed from symptoms and changes in your periods.

What the latest research says

The BMJ Open study echoes other recent work. In Australia, a review of nearly 500 tests sold directly to the public found that most had little medical value and that healthy people were the main target. In the UK, a 2025 investigation in The BMJ of self-tests sold in pharmacies and supermarkets found that accuracy claims often rested on poorly designed or unavailable studies, and that many instructions were hard to follow.

Laboratory medicine specialists writing in Clinical Chemistry point out that a test ordered without a health professional loses some of the usual safeguards: choosing the right test, collecting the sample properly and interpreting the result in context. An international consensus reached the same conclusion about gut microbiome tests sold to consumers, whose clinical value has not been shown. In the US, regulatory experts have argued for clearer rules on clinical oversight of direct-to-consumer tests. What it means for you: a test is only as useful as the question it answers and what you will do with the result.

When to see a doctor

  • If you have symptoms (unusual tiredness, weight loss, bleeding, persistent pain): see a doctor rather than buying a test, and do not let a normal result reassure you.
  • If an online test or home test comes back abnormal: have it confirmed by an accredited lab and show it to your doctor, without panicking or starting treatment on your own.
  • If you have a family history of high cholesterol, diabetes or cancer: ask whether you should start screening earlier or test more often.
  • In an emergency, call 911.

Glossary

  • Direct-to-consumer test: a test you order and pay for yourself, without a clinician's order.
  • False positive: an abnormal result in someone who does not have the condition.
  • False negative: a normal result in someone who does have the condition.
  • Overdiagnosis: finding an abnormality that would never have caused health problems.
  • HbA1c: glycated hemoglobin, a measure of average blood sugar over the past two to three months.
  • FSH: follicle-stimulating hormone, which varies with the menstrual cycle and during perimenopause.
  • qFIT: quantitative fecal immunochemical test, which looks for hidden blood in stool.

Frequently asked questions

Are at-home blood tests accurate?

FDA-cleared tests used exactly as instructed can give useful information, but accuracy also depends on collecting the sample correctly. An abnormal result should be confirmed by a lab and reviewed with a doctor.

Is a full-body checkup worth it if I feel fine?

Not usually. Tests chosen for your age and risk factors are more useful than a long list of markers, which raises the chance of false alarms.

Can I order blood work without a doctor in the US?

In most states, yes, through direct-to-consumer lab services. You still need someone to help you interpret the results and decide what to do next.

What should I do with an out-of-range result?

A small, isolated deviation is common in healthy people. Look at the whole report, repeat the test if needed and talk to your doctor before drawing conclusions.

Which screening tests are recommended for adults?

The USPSTF recommends, among others, mammograms from 40, colorectal cancer screening from 45 and diabetes screening from 35 in people with overweight or obesity. Your doctor can tailor this list to you.

Sources

Further reading

Understand your own blood test results with AI DiagMe

Did you get a lab report, whether your doctor ordered it or you did, and you are not sure what the out-of-range values mean? Upload it to AI DiagMe to get a clear, personalized explanation of every result in minutes, and prepare for your conversation with your doctor.

Editorial team

  • AI DiagMe

    Author

    The AI DiagMe team brings together physicians, clinical specialists, and medical editors. Our articles are written by health communication professionals and then reviewed and validated by the physicians of our scientific committee, composed of practicing hospital physicians in specialties such as hematology, endocrinology, and general medicine. Julien Priour, who leads the editorial mission, holds an MBA from HEC Paris and was trained in scientific writing and publishing by the French National Research Institute for Sustainable Development (IRD, FUN-MOOC, 2026). Each piece of content is based on current clinical guidelines and peer-reviewed medical publications.

    Email Website
  • Julien Priour

    Edited by

    Co-founder and CEO of AI DiagMe · Senior medical editor · HEC Paris graduate

    Julien Priour is a senior medical editor at AI DiagMe, where he oversees the editorial line and the fact-checking process. A graduate of HEC Paris, he has 3 years of experience in health publishing and was trained in scientific writing and publishing by the French National Research Institute for Sustainable Development (IRD, FUN-MOOC, 2026). He makes sure that every article follows current medical guidelines and is reviewed and validated by a physician from the scientific and ethics committee. He sets the sourcing standards (HAS, Ameli, INSERM…) and the review standards applied across the entire site.

    Email LinkedIn
  • Dr. Claude Tchonko

    Medically reviewed by

    Dr. Claude Tchonko is a hematologist, in practice since 2013, currently working at Clinique Mas de Rochet (Castelnau-le-Lez, France). With an international background, he specializes in the management of hematologic malignancies (leukemias, lymphomas, myelomas), with particular expertise in autologous stem cell transplantation, CAR-T cell therapy and the optimization of care pathways in onco-hematology.

    Author of a reference work, “Lymphoid Hematologic Malignancies in Mali”, he combines clinical practice with active involvement in projects developing technology solutions for healthcare.

    He holds a State Doctorate in Medicine (Faculty of Medicine of Bamako, 2006) and completed his training with a Certificate of Specialized Studies in Bioclinical Hematology (Abidjan-Cocody, 2010) and several university diplomas: a DFMS in Hematology and an inter-university diploma (DIU) in Onco-Hematological Cytogenetics (Grenoble), as well as a university diploma (DU) in major sickle cell disease (UPEC).

    Dr. Claude Tchonko LinkedIn

Related Posts

Coming Soon